Literature DB >> 1687167

Dopamine receptor subtypes and formalin test analgesia.

M J Morgan1, K B Franklin.   

Abstract

The role played by dopamine D1 and D2 receptors in formalin test analgesia was explored by challenging D-amphetamine- and morphine-induced analgesia with mixed and selective D1 and D2 antagonists, and by examining the relative analgesic activity of mixed and selective D1 and D2 agonists. The mixed D1/D2 dopamine antagonist cis-flupenthixol (0.5 mg/kg), the D2 antagonist pimozide (0.5 mg/kg), and the D1 antagonist SCH 23390 (0.1 mg/kg) attenuated both D-amphetamine and morphine analgesia. The mixed D1/D2 agonist apomorphine and the selective D2 agonist quinpirole produced dose-dependent analgesia while the selective D1 agonist SKF 38393 was without effect. These data suggest that D1 receptors play an "enabling" role in D2 receptor-mediated analgesia in the formalin test.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1687167     DOI: 10.1016/0091-3057(91)90560-o

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  14 in total

1.  Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat.

Authors:  Thomas C Jhou; Sheng-Ping Xu; Mary R Lee; Courtney L Gallen; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2012-06-06       Impact factor: 4.530

Review 2.  Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions.

Authors:  Michel Barrot; Susan R Sesack; François Georges; Marco Pistis; Simon Hong; Thomas C Jhou
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

3.  Enhanced antinociception with repeated microinjections of apomorphine into the periaqueductal gray of male and female rats.

Authors:  Shauna M Schoo; Erin N Bobeck; Michael M Morgan
Journal:  Behav Pharmacol       Date:  2018-04       Impact factor: 2.293

4.  Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system.

Authors:  M A King; S Bradshaw; A H Chang; J E Pintar; G W Pasternak
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception.

Authors:  A R Burkey; E Carstens; L Jasmin
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

6.  Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors.

Authors:  Matthew F Lazenka; Kelen C Freitas; Sydney Henck; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2017-04-14       Impact factor: 4.030

7.  Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice.

Authors:  Cruz M Cendán; José M Pujalte; Enrique Portillo-Salido; José M Baeyens
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

8.  Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.

Authors:  Axel Becker; Gisela Grecksch; Gerald Zernig; Elisabeth Ladstaetter; Christoph Hiemke; Ulrich Schmitt
Journal:  Psychopharmacology (Berl)       Date:  2008-09-23       Impact factor: 4.530

9.  Chronic Back Pain Is Associated with Alterations in Dopamine Neurotransmission in the Ventral Striatum.

Authors:  Ilkka K Martikainen; Emily B Nuechterlein; Marta Peciña; Tiffany M Love; Chelsea M Cummiford; Carmen R Green; Christian S Stohler; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2015-07-08       Impact factor: 6.167

10.  Antinociceptive Activity of Trichilia catigua Hydroalcoholic Extract: New Evidence on Its Dopaminergic Effects.

Authors:  Alice F Viana; Izaque S Maciel; Emerson M Motta; Paulo C Leal; Luiz Pianowski; Maria M Campos; João B Calixto
Journal:  Evid Based Complement Alternat Med       Date:  2011-04-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.